# Can-Fite BioPharma Ltd.: Form 6-K, filed Mar 3, 2026

- Company: [Can-Fite BioPharma Ltd.](/companies/canf.md) (CIK 1536196)
- Form: 6-K
- Filed: 2026-03-03
- Accepted by EDGAR: Mar 3, 2026, 16:39 ET
- Period: 2026-03-03
- Accession: 0001213900-26-023095
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1536196/000121390026023095/ea0279634-6k_can.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1536196/000121390026023095/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1536196/000121390026023095/ea0279634-6k_can.htm

Filed Mar 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-023095. Last ingested by Listed: Nov 12, 2026, 17:45 ET. No prices; not investment advice.